Literature DB >> 25937280

Chronic optogenetic activation augments aβ pathology in a mouse model of Alzheimer disease.

Kaoru Yamamoto1, Zen-Ichi Tanei2, Tadafumi Hashimoto1, Tomoko Wakabayashi1, Hiroyuki Okuno3, Yasushi Naka1, Ofer Yizhar4, Lief E Fenno4, Masashi Fukayama5, Haruhiko Bito3, John R Cirrito6, David M Holtzman6, Karl Deisseroth4, Takeshi Iwatsubo7.   

Abstract

In vivo experimental evidence indicates that acute neuronal activation increases Aβ release from presynaptic terminals, whereas long-term effects of chronic synaptic activation on Aβ pathology remain unclear. To address this issue, we adopted optogenetics and transduced stabilized step-function opsin, a channelrhodopsin engineered to elicit a long-lasting neuronal hyperexcitability, into the hippocampal perforant pathway of APP transgenic mice. In vivo microdialysis revealed a ∼24% increase in the hippocampal interstitial fluid Aβ42 levels immediately after acute light activation. Five months of chronic optogenetic stimulation increased Aβ burden specifically in the projection area of the perforant pathway (i.e., outer molecular layer of the dentate gyrus) of the stimulated side by ∼2.5-fold compared with that in the contralateral side. Epileptic seizures were observed during the course of chronic stimulation, which might have partly contributed to the Aβ pathology. These findings implicate functional abnormalities of specific neuronal circuitry in Aβ pathology and Alzheimer disease.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25937280     DOI: 10.1016/j.celrep.2015.04.017

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  76 in total

Review 1.  [Mechanisms of Alzheimer's disease : Neuronal hyperactivity and hypoactivity as new therapeutic targets].

Authors:  M A Busche; M Staufenbiel; M Willem; C Haass; H Förstl
Journal:  Nervenarzt       Date:  2016-11       Impact factor: 1.214

2.  BACE inhibition-dependent repair of Alzheimer's pathophysiology.

Authors:  Aylin D Keskin; Maja Kekuš; Helmuth Adelsberger; Ulf Neumann; Derya R Shimshek; Beomjong Song; Benedikt Zott; Tingying Peng; Hans Förstl; Matthias Staufenbiel; Israel Nelken; Bert Sakmann; Arthur Konnerth; Marc Aurel Busche
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205

Review 3.  Epileptic activity in Alzheimer's disease: causes and clinical relevance.

Authors:  Keith A Vossel; Maria C Tartaglia; Haakon B Nygaard; Adam Z Zeman; Bruce L Miller
Journal:  Lancet Neurol       Date:  2017-04       Impact factor: 44.182

4.  Altered Cortical and Hippocampal Excitability in TgF344-AD Rats Modeling Alzheimer's Disease Pathology.

Authors:  Milan Stoiljkovic; Craig Kelley; Bernardo Stutz; Tamas L Horvath; Mihály Hajós
Journal:  Cereb Cortex       Date:  2019-06-01       Impact factor: 5.357

Review 5.  Network abnormalities and interneuron dysfunction in Alzheimer disease.

Authors:  Jorge J Palop; Lennart Mucke
Journal:  Nat Rev Neurosci       Date:  2016-11-10       Impact factor: 34.870

Review 6.  Cellular mechanisms responsible for cell-to-cell spreading of prions.

Authors:  Didier Vilette; Josquin Courte; Jean Michel Peyrin; Laurent Coudert; Laurent Schaeffer; Olivier Andréoletti; Pascal Leblanc
Journal:  Cell Mol Life Sci       Date:  2018-05-14       Impact factor: 9.261

7.  Gamma Entrainment Binds Higher-Order Brain Regions and Offers Neuroprotection.

Authors:  Chinnakkaruppan Adaikkan; Steven J Middleton; Asaf Marco; Ping-Chieh Pao; Hansruedi Mathys; David Nam-Woo Kim; Fan Gao; Jennie Z Young; Ho-Jun Suk; Edward S Boyden; Thomas J McHugh; Li-Huei Tsai
Journal:  Neuron       Date:  2019-05-07       Impact factor: 17.173

8.  Miniaturized, Battery-Free Optofluidic Systems with Potential for Wireless Pharmacology and Optogenetics.

Authors:  Kyung Nim Noh; Sung Il Park; Raza Qazi; Zhanan Zou; Aaron D Mickle; Jose G Grajales-Reyes; Kyung-In Jang; Robert W Gereau; Jianliang Xiao; John A Rogers; Jae-Woong Jeong
Journal:  Small       Date:  2017-12-07       Impact factor: 13.281

9.  Nav1.1-Overexpressing Interneuron Transplants Restore Brain Rhythms and Cognition in a Mouse Model of Alzheimer's Disease.

Authors:  Magdalena Martinez-Losa; Tara E Tracy; Keran Ma; Laure Verret; Alexandra Clemente-Perez; Abdullah S Khan; Inma Cobos; Kaitlyn Ho; Li Gan; Lennart Mucke; Manuel Alvarez-Dolado; Jorge J Palop
Journal:  Neuron       Date:  2018-03-15       Impact factor: 17.173

Review 10.  Optogenetics for neurodegenerative diseases.

Authors:  Kiara T Vann; Zhi-Gang Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.